Exploiting cholera vaccines as a versatile antigen delivery platform
- PMID: 18008168
- PMCID: PMC2753531
- DOI: 10.1007/s10529-007-9594-0
Exploiting cholera vaccines as a versatile antigen delivery platform
Abstract
The development of safe, immunogenic and protective cholera vaccine candidates makes possible their use as a versatile antigen delivery platform. Foreign antigens can be delivered to the immune system with cholera vaccines by expressing heterologous antigens in live attenuated vectors, as fusion proteins with cholera toxin subunits combined with inactivated Vibrio cholerae whole cells or by exposing them on the surface of V. cholerae ghosts. Progress in our understanding of the genes expressed by V. cholerae during infection creates unprecedented opportunities to develop an improved generation of vaccine vectors to induce immune protection against a broad range of pathogenic organisms.
Similar articles
-
Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.mSphere. 2018 Jun 6;3(3):e00245-18. doi: 10.1128/mSphere.00245-18. Print 2018 Jun 27. mSphere. 2018. PMID: 29875145 Free PMC article.
-
Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;270(1-2):260-9. doi: 10.1016/s0176-6724(88)80162-7. Zentralbl Bakteriol Mikrobiol Hyg A. 1988. PMID: 2464884
-
Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.mSphere. 2019 Aug 21;4(4):e00206-19. doi: 10.1128/mSphere.00206-19. mSphere. 2019. PMID: 31434744 Free PMC article.
-
Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.Vaccine. 2004 Jun 23;22(19):2457-69. doi: 10.1016/j.vaccine.2003.12.033. Vaccine. 2004. PMID: 15193410 Review.
-
Cholera vaccines.Clin Infect Dis. 2000 Aug;31(2):561-5. doi: 10.1086/313951. Epub 2000 Sep 7. Clin Infect Dis. 2000. PMID: 10987721 Review.
Cited by
-
A Self-Assembling Whole-Cell Vaccine Antigen Presentation Platform.J Bacteriol. 2018 Jul 10;200(15):e00752-17. doi: 10.1128/JB.00752-17. Print 2018 Aug 1. J Bacteriol. 2018. PMID: 29483163 Free PMC article.
-
Modelling the impact of vaccination on cholera transmission dynamics under stratified populations and seasonality.Infect Dis Model. 2025 Jun 23;10(4):1138-1152. doi: 10.1016/j.idm.2025.06.006. eCollection 2025 Dec. Infect Dis Model. 2025. PMID: 40678793 Free PMC article.
-
Live bacterial vaccine vectors: an overview.Braz J Microbiol. 2015 Mar 4;45(4):1117-29. doi: 10.1590/s1517-83822014000400001. eCollection 2014. Braz J Microbiol. 2015. PMID: 25763014 Free PMC article. Review.
-
Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR.FEMS Immunol Med Microbiol. 2009 Oct;57(1):69-79. doi: 10.1111/j.1574-695X.2009.00580.x. Epub 2009 Jul 1. FEMS Immunol Med Microbiol. 2009. PMID: 19678844 Free PMC article.
-
Attenuation of bacterial virulence by quorum sensing-regulated lysis.J Biotechnol. 2010 Oct 1;150(1):22-30. doi: 10.1016/j.jbiotec.2010.07.025. Epub 2010 Jul 29. J Biotechnol. 2010. PMID: 20673838 Free PMC article.
References
-
- Bäckström MM, Lebens F, Schödel F, Holmgren J. Insertion of a HIV-neutralizing epitope in a surface-exposed internal region of the cholera toxin B subunit. Gene. 1994;149:211–217. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources